FIELD: medicine, pharmaceutics.
SUBSTANCE: invention claims a drug applicable in treatment of psychoverbal development retention of various etiology (dysarthria). It consists of triethanolamine fumaric acid salt (fumarate tris-2-oxyethylammonium) previously used as antioxidant and immune modulator.
EFFECT: improved attention, memory, metabolic processes in nervous system, reduced encephalasthenia level, increased psychic and verbal activity.
8 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| APPLICATION OF TRYPTOPHAN FOR TREATMENT OF PSYCHOVERBAL DEVELOPMENT RETARDATION IN CASE OF NEURO-PSYCHIC DISEASES | 2008 |
|
RU2395279C2 |
| APPLICATION OF MADOPAR FOR CORRECTION OF COGNITIVE, MOTIVATION, EMOTIONAL DISTURBANCES IN CHILDREN WITH AUTISTIC SPECTRUM DISORDERS | 2008 |
|
RU2403034C2 |
| APPLICATION OF GLIATILIN AND TRANSCRANIAL MICROPOLARISATION IN TREATMENT OF CHILDREN WITH AUTISTIC DISTURBANCES | 2009 |
|
RU2429831C2 |
| METHOD OF EVALUATING LIMITATION OF VITAL ACTIVITY OF CHILDREN WITH PSYCHONEUROLOGICAL PROFILE | 2009 |
|
RU2391899C1 |
| MEDICINAL AGENT FOR TREATMENT OF CHRONIC HEPATITIS B | 2006 |
|
RU2313337C1 |
| METHOD FOR TREATMENT OF NERVOUS SYSTEM DISORDER IN CHILDREN OF YOUNGEST AGE AND PHARMACEUTICAL COMPOSITION | 2003 |
|
RU2241487C1 |
| APPLICATION OF FUMARIC ACID FOR PRESERVATION OF MUSK DEER MUSK | 2008 |
|
RU2385001C1 |
| ANTISTRESS, STRESS-PROTECTIVE, NOOTROPIC AGENT, METHOD OF PROPHYLAXIS AND TREATMENT OF STRESS STATES AND A METHOD OF MENTAL WORKIN CAPACITY INCREASE | 1992 |
|
RU2025124C1 |
| APPLICATION OF ATOMOXETINE HYDROCHLORIDE, PULSE LOW-INTENSITY ELECTROMAGNETIC FIELD AND OXYGEN COCKTAIL IN CHILDREN WITH MINIMAL BRAIN DYSFUNCTION ASSOCIATING HYPERACTIVITY | 2009 |
|
RU2428226C1 |
| METHOD OF TREATING AUTISM SPECTRUM DISORDERS | 2019 |
|
RU2716754C2 |
